Spyre Therapeutics (SYRE) has an average rating of buy and mean price target of $96.07, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $81.49, Change: $+0.70, Percent Change: +0.87%